"Sahyadri Super Speciality Hospital Deccan Gymkhana is a 202 bedded with the right blend of experienced expertise, latest technology and professional management to provide high quality medical care. Highlights : - Fastest growing Liver Transplant Centre in Western India - Performing highest number of CT Angiographies in Asia. - Highest number of MRIs in Pune. - Highest number of Neurosurgeries in Pune. - Highest number of Bone Marrow Transplants in Western India. - Sahyadri Medical Genetics : A Unique Comprehensive Facility offering Clinical, Diagnostic and Therapeutic Services in Genetics."

During the past decade, Sahyadri Speciality Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 16 clinical trials were completed, i.e. on average, 177.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sahyadri Speciality Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sahyadri Speciality Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "BioMérieux" with 1 trials as a collaborator, "Centre Hospitalier Régional et Universitaire de Brest" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sahyadri Speciality Hospital" are "Epilepsies, Partial" (2 trials), "Influenza A" (2 trials), "Alcoholic Liver Cirrhosis" (1 trials), "Anemia" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Sahyadri Speciality Hospital" in a lesser frequency.

Most popular intervention types in "Sahyadri Speciality Hospital" are "Drug" (19 trials), "Biological" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "placebo" (3 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sahyadri Speciality Hospital" are 20 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sahyadri Speciality Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Sahyadri Speciality Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sahyadri Speciality Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".